Bioengineered miR‐328‐3p modulates SLC2A1/GLUT1‐mediated glucose uptake and metabolism to exert synergistic antiproliferative effects with chemotherapeutics
-
Published:2020-04
Issue:S1
Volume:34
Page:1-1
-
ISSN:0892-6638
-
Container-title:The FASEB Journal
-
language:en
-
Short-container-title:The FASEB Journal
Author:
Tu Mei-Juan1,
Yi Wan-Yong1,
Liu Zhenzhen1,
Zhang Chao1,
Yu Ai-Xi2,
Yu Ai-Ming1
Affiliation:
1. UC Davis School of Medicine
2. Zhongnan Hospital of Wuhan University
Subject
Genetics,Molecular Biology,Biochemistry,Biotechnology